- Home
- WF vs BRKR Comparison
WF vs BRKR Comparison
Compare WF & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WF
- BRKR
- Stock Information
- Founded
- WF 1899
- BRKR 1991
- Country
- WF South Korea
- BRKR United States
- Employees
- WF N/A
- BRKR N/A
- Industry
- WF Commercial Banks
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- WF Finance
- BRKR Industrials
- Exchange
- WF Nasdaq
- BRKR Nasdaq
- Market Cap
- WF 7.8B
- BRKR 9.2B
- IPO Year
- WF N/A
- BRKR 2000
- Fundamental
- Price
- WF $32.05
- BRKR $61.26
- Analyst Decision
- WF
- BRKR Buy
- Analyst Count
- WF 0
- BRKR 13
- Target Price
- WF N/A
- BRKR $75.67
- AVG Volume (30 Days)
- WF 60.4K
- BRKR 1.4M
- Earning Date
- WF 11-14-2024
- BRKR 02-11-2025
- Dividend Yield
- WF 11.45%
- BRKR 0.33%
- EPS Growth
- WF N/A
- BRKR N/A
- EPS
- WF 2.64
- BRKR 2.06
- Revenue
- WF $7,567,454,676.00
- BRKR $3,241,300,000.00
- Revenue This Year
- WF N/A
- BRKR $15.23
- Revenue Next Year
- WF $1.44
- BRKR $7.52
- P/E Ratio
- WF $4.01
- BRKR $30.54
- Revenue Growth
- WF N/A
- BRKR 15.00
- 52 Week Low
- WF $27.60
- BRKR $48.07
- 52 Week High
- WF $38.05
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- WF 45.51
- BRKR 58.41
- Support Level
- WF $31.03
- BRKR $58.78
- Resistance Level
- WF $31.50
- BRKR $64.64
- Average True Range (ATR)
- WF 0.48
- BRKR 1.98
- MACD
- WF 0.15
- BRKR 0.39
- Stochastic Oscillator
- WF 76.87
- BRKR 59.23
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holdings company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. Its operating segments include Banking, Credit card, capital, Investment banking, and others.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.